Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
33709 Results Found
CMS announces primary care model participants
The Centers for Medicare & Medicaid Services has selected 916 primary care practices and 37 regional health plan partners to participate in the Primary Care First model beginning Jan. 1.
CMS webinar Dec. 8 on hospital price transparency rule
The Centers for Medicare & Medicaid Services will host a Dec. 8 webinar on its final rule requiring hospitals to disclose payer-specific negotiated rates effective Jan. 1.
Trump administration unveils two drug pricing policies
The Trump administration announced two actions that it claims will lower prescription drug prices.
HHS releases final rules removing barriers to coordinated care
The Department of Health and Human Services released its final rules with changes to the Stark Law and Anti-kickback statute. AHA members will receive a Special Bulletin highlighting key changes.
AHA Leadership Rounds on moving from recovery to innovation
Sarah Krevans, president and CEO of Sutter Health, joined AHA Board Chair Melinda Estes, M.D., yesterday to discuss how hospitals can move from relief, recovery, and rebuilding to reimagining and innovation.
HHS launches fast molecular testing pilot
The Department of Health and Human Services recently distributed 27,000 portable COVID-19 molecular test kits, which Alaska, Florida, Louisiana, New Jersey, and Texas can use at the point of care to verify antigen test results within 20 minutes.
FDA authorizes drug combination to treat hospitalized COVID-19 patients
The Food and Drug Administration authorized the emergency use of baricitinib in combination with remdesivir to treat suspected or laboratory confirmed COVID-19 in certain hospitalized patients requiring supplemental oxygen, invasive mechanical ventilation or extracorporeal membrane oxygenation.
Pfizer applies for EUA for COVID-19 vaccine candidate
Pfizer Inc. announced it will request emergency use authorization from the Food and Drug Administration for its BNT162b2 mRNA vaccine candidate against SARS-CoV-2.
Chair File: A New Depth of Gratitude
This year, with so much to worry about, finding time for gratitude seems almost impossible. The irony, of course, is that we need it now more than ever. We just need to look for it.